Iridoid glycosides isolated from Oldenlandia diffusa inhibit LDL-oxidation

Archives of Pharmacal Research

Volumn 28, Issue 10, 2005, Pages 1156-1160

  Kim, Dong Hyun ^a   Lee, Hyo Jung ^a   Oh, Young Jun ^a   Kim, Min Jung ^b   Kim, Sung Hoon ^a   Jeong, Tae Sook ^b   Baek, Nam In ^a  

^a Kyung Hee University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Iridoid; LDL Oxidation inhibition; Oldenlandia diffusa; Oldenlandoside III; Rubiaceae

Indexed keywords

EID: 27744441241     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02972979     Document Type: Article

References (23)

1. Ahn, B. T., Lee, S. K., Lee, S. B., Lee, E. S., Kim, J. G., and Bok, S. H., Low-density lipoprotein-antioxidant constituents of Saururus chinensis. J. Nat. Prod., 64, 1562-1564 (2001).
2. Bjorkhem, I., Freyschuss, A. H., Breuer, O., Diczfalusy, U., Berglund, L., and Henriksson, P., The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler. Thromb., 11, 15-22 (1991).
3. Buege, J. A. and Aust, S. D., Microsomal lipid peroxidation. Methods Enzymol., 52, 302-310 (1978).
4. Carew, T. E., Schwenke, D. C., and Steinberg, D., Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. U.S.A., 84, 7725-7729 (1987).
5. Daugherty, A., Zweifel, B. S., and Schonfeld, G., Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Br. J. Pharmacol., 98, 612-618 (1989).
6. El-nagar, L. J., and Beal, J. L., Iridoids. A review. J. Nat. Prod., 43, 649-707 (1980).
7. Ho, T. I., Chen, G. P., Lin, Y. C., Lin, Y. M., and Chen, F. C., An anthraquinone from Hedyotis diffusa. Phytochemistry, 25, 1988-1989 (1986).
8. Inouye, H., Takeda, Y., Nishimura, H., and Nishimura H., Two new iridoid glucosides from Gardenia jasminoides fruits. Phytochemistry, 13, 2219-2224 (1974).
9. Jeong, T. S., Kim, K. S., Kim, J. R., Cho, K. H., Lee, S. K., and Lee, W. S., Novel 3,5-diaryl pyrazolines and pyrazole as lowdensity lipoprotein (LDL) oxidation inhibitor. Bioorg. Med. Chem. Lett., 14, 2719-2723 (2004).
10. Jung, B. S. and Shin, M. K., In 'Hyang Yak Dae Sa Jun'. Young Lim Sa (3rd Ed.), Seoul, Korea (1990).
11. Kamiya, K., Fujita, Y., Saiki, Y., Hanani, E., Mansur, U., and Satake, T., Studies on the constituents of Indonesian Borreria latifolia. Heterocycles, 56, 537-544 (2002).
12. Kim, Y. H., Studies on the constituents of Oldenlandia diffusa. Kor. J. Medicinal Crop Sci., 3, 91-95 (1995).
13. Kita, T., Nagano, Y., Yokode, M., Ishii, K., Kume, N., Ooshima, A., Yoshida, H., and Kawai, C., Probucol prevents the progression of atherosclerosis in watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. U.S.A., 84, 5928-5931 (1987).
14. Lopes, S., Poser, G. L., Kerber, V. A., Farias, F. M., Konrath, E. L., Moreno, P., Sobral, M. E., Zuanazzi, J. A. S., and Henriques, A. T., Taxonomic significance of alkaloids and iridoid glucosides in the tribe Psychotrieae (Rubiaceae). Biochem. Syst. Ecol., 32, 1187-1195 (2004).
15. Nagano, Y., Nakamura, T., Matsuzawa, Y., Cho, M., Ueda, Y., and Kita, T., Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit - long-term antiatherogenic effect and effects on established plaques. Atherosclerosis, 92, 131-140 (1992).
16. Nishihama, Y., Masuda, K., Yamaki, M., Takagi, S., and Sakina, K., Three new iridoid glucosides from Hedyotis diffusa. Planta Med., 43, 28-33 (1981).
17. Otsuka, H., Yoshimura, K., Yamasaki, K., and Cantoria, M. C., Isolation of 10-O-acyl iridoid glucosides from a Philippine medicinal plant, Oldenlandia corymbosa L. (Rubiaceae). Chem. Pharm. Bull., 39, 2049-2052 (1991).
18. Rimm, E. B., Stampfer, M. J., Ascherio, A., Giovannucci, E., Colditz, G. A., and Willett, W. C., Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med., 328, 1450-1456 (1993).
19. Sasahara, M., Raines, E. W., Chait, A., Carew, T. E., Steinberg, D., Wahl, P. W., and Ross, R., Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation? J. Clin. Invest., 94, 155-164 (1994).
20. Seo, S., Tomita, Y., Tori, K., and Yoshimura, Y., Determination of the absolute configuration of a secondary hydroxy group in a chiral secondary alcohol using glycosidation shifts in carbon-13 nuclear magnetic resonance spectroscopy. J. Am. Chem. Soc., 100, 3331-3339 (1978).
21. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., and Witztum, J. L., Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med., 320, 915-924 (1989).
22. Takagi, S., Yamaki, M., Nishihama, Y., and Ishiguro, K., On the iridoid glucosides of the Chinese drug "bai hua she she cao". Shoyakugaku Zasshi, 36, 366-369 (1982).
23. Takeda, Y., Nishimura, H., and Inouye, H., Two new iridoid glucosides from Ixora chinensis. Phytochemistry, 14, 2647-2650 (1975).